Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

135907764 113020 None 15 Human Functional pEC50 = 5.9 5.9 -18 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 319 4 1 5 3.5 N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CC1 10.6019/CHEMBL5442687
CHEMBL3310783 113020 None 15 Human Functional pEC50 = 5.9 5.9 -18 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 319 4 1 5 3.5 N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CC1 10.6019/CHEMBL5442687
11316919 3068 None 31 Human Functional pEC50 = 4.8 4.8 -32 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 451 4 0 4 5.3 Clc1c(cccc1)n1nc2C(=O)N(CCOc2c1c1ccc(cc1)Cl)CC(C)(F)F 10.6019/CHEMBL5442687
11693 3068 None 31 Human Functional pEC50 = 4.8 4.8 -32 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 451 4 0 4 5.3 Clc1c(cccc1)n1nc2C(=O)N(CCOc2c1c1ccc(cc1)Cl)CC(C)(F)F 10.6019/CHEMBL5442687
CHEMBL484929 3068 None 31 Human Functional pEC50 = 4.8 4.8 -32 8
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 451 4 0 4 5.3 Clc1c(cccc1)n1nc2C(=O)N(CCOc2c1c1ccc(cc1)Cl)CC(C)(F)F 10.6019/CHEMBL5442687
11858154 155430 None 19 Human Functional pEC50 = 6.5 6.5 -309 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 400 6 3 7 3.3 C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2F)nc2[nH]c(=O)sc12 10.6019/CHEMBL5442687
CHEMBL403225 155430 None 19 Human Functional pEC50 = 6.5 6.5 -309 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 400 6 3 7 3.3 C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2F)nc2[nH]c(=O)sc12 10.6019/CHEMBL5442687
2705 3842 None 44 Human Functional pEC50 = 5.4 5.4 -575 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.6019/CHEMBL5442687
360 3842 None 44 Human Functional pEC50 = 5.4 5.4 -575 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.6019/CHEMBL5442687
443879 3842 None 44 Human Functional pEC50 = 5.4 5.4 -575 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.6019/CHEMBL5442687
443879.0 3842 None 44 Human Functional pEC50 = 5.4 5.4 -575 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.6019/CHEMBL5442687
CHEMBL1382 3842 None 44 Human Functional pEC50 = 5.4 5.4 -575 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.6019/CHEMBL5442687
DB01036 3842 None 44 Human Functional pEC50 = 5.4 5.4 -575 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.6019/CHEMBL5442687
3036864 205211 None 16 Human Functional pEC50 = 5.4 5.4 -9549 13
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 287 1 1 2 3.7 CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1 10.6019/CHEMBL5442687
CHEMBL1256645 205211 None 16 Human Functional pEC50 = 5.4 5.4 -9549 13
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 287 1 1 2 3.7 CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1 10.6019/CHEMBL5442687
CHEMBL1814790 205211 None 16 Human Functional pEC50 = 5.4 5.4 -9549 13
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 287 1 1 2 3.7 CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1 10.6019/CHEMBL5442687
CHEMBL62 205211 None 16 Human Functional pEC50 = 5.4 5.4 -9549 13
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 287 1 1 2 3.7 CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1 10.6019/CHEMBL5442687
9887803 140924 None 26 Human Functional pEC50 = 6.4 6.4 -19 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 409 3 4 4 3.6 NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O 10.6019/CHEMBL5442687
CHEMBL3819292 140924 None 26 Human Functional pEC50 = 6.4 6.4 -19 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 409 3 4 4 3.6 NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O 10.6019/CHEMBL5442687
24780598 1316 None 38 Human Functional pEC50 = 6.1 6.1 -85 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 441 4 4 5 3.7 O=C(Nc1cccc(c1C)F)Nc1ccc(c(c1O)S(=O)(=O)[C@H]1CCCNC1)Cl 10.6019/CHEMBL5442687
8500 1316 None 38 Human Functional pEC50 = 6.1 6.1 -85 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 441 4 4 5 3.7 O=C(Nc1cccc(c1C)F)Nc1ccc(c(c1O)S(=O)(=O)[C@H]1CCCNC1)Cl 10.6019/CHEMBL5442687
CHEMBL3039531 1316 None 38 Human Functional pEC50 = 6.1 6.1 -85 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 441 4 4 5 3.7 O=C(Nc1cccc(c1C)F)Nc1ccc(c(c1O)S(=O)(=O)[C@H]1CCCNC1)Cl 10.6019/CHEMBL5442687
DB11922 1316 None 38 Human Functional pEC50 = 6.1 6.1 -85 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 441 4 4 5 3.7 O=C(Nc1cccc(c1C)F)Nc1ccc(c(c1O)S(=O)(=O)[C@H]1CCCNC1)Cl 10.6019/CHEMBL5442687
11250647 1545 None 35 Human Functional pEC50 = 5.0 5.0 -2511 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 631 12 2 7 5.5 COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F 10.6019/CHEMBL5442687
11250647.0 1545 None 35 Human Functional pEC50 = 5.0 5.0 -2511 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 631 12 2 7 5.5 COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F 10.6019/CHEMBL5442687
5293 1545 None 35 Human Functional pEC50 = 5.0 5.0 -2511 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 631 12 2 7 5.5 COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F 10.6019/CHEMBL5442687
8362 1545 None 35 Human Functional pEC50 = 5.0 5.0 -2511 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 631 12 2 7 5.5 COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F 10.6019/CHEMBL5442687
CHEMBL1208155 1545 None 35 Human Functional pEC50 = 5.0 5.0 -2511 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 631 12 2 7 5.5 COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F 10.6019/CHEMBL5442687
DB11979 1545 None 35 Human Functional pEC50 = 5.0 5.0 -2511 7
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 631 12 2 7 5.5 COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F 10.6019/CHEMBL5442687
6603703 208 None 8 Human Functional pIC50 = 5.8 5.8 -524 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
9637 208 None 8 Human Functional pIC50 = 5.8 5.8 -524 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
CHEMBL291143 208 None 8 Human Functional pIC50 = 5.8 5.8 -524 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
662 3680 None 7 Human Functional pIC50 = 5.7 5.7 1 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
9853583 3680 None 7 Human Functional pIC50 = 5.7 5.7 1 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
CHEMBL2021721 3680 None 7 Human Functional pIC50 = 5.7 5.7 1 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
1692 2154 None 25 Human Functional pIC50 = 5.6 5.6 -87 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
5311340 2154 None 25 Human Functional pIC50 = 5.6 5.6 -87 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
CHEMBL140979 2154 None 25 Human Functional pIC50 = 5.6 5.6 -87 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
10150497 4074 None 40 Human Functional pIC50 = 5.5 5.5 -457 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
3240 4074 None 40 Human Functional pIC50 = 5.5 5.5 -457 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
CHEMBL392760 4074 None 40 Human Functional pIC50 = 5.5 5.5 -457 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
209 3057 None 57 Human Functional pIC50 = 5.5 5.5 -1288 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
2113 3057 None 57 Human Functional pIC50 = 5.5 5.5 -1288 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
4748 3057 None 57 Human Functional pIC50 = 5.5 5.5 -1288 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
4748.0 3057 None 57 Human Functional pIC50 = 5.5 5.5 -1288 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
CHEMBL567 3057 None 57 Human Functional pIC50 = 5.5 5.5 -1288 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
DB00850 3057 None 57 Human Functional pIC50 = 5.5 5.5 -1288 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.6019/CHEMBL5442687
1209 1658 None 52 Human Functional pIC50 = 5.5 5.5 -25 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
203 1658 None 52 Human Functional pIC50 = 5.5 5.5 -25 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
3386 1658 None 52 Human Functional pIC50 = 5.5 5.5 -25 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
CHEMBL41 1658 None 52 Human Functional pIC50 = 5.5 5.5 -25 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
DB00472 1658 None 52 Human Functional pIC50 = 5.5 5.5 -25 25
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
2419 3463 None 53 Human Functional pIC50 = 5.5 5.5 -5623 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
5152 3463 None 53 Human Functional pIC50 = 5.5 5.5 -5623 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
5152.0 3463 None 53 Human Functional pIC50 = 5.5 5.5 -5623 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
559 3463 None 53 Human Functional pIC50 = 5.5 5.5 -5623 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
CHEMBL1263 3463 None 53 Human Functional pIC50 = 5.5 5.5 -5623 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
DB00938 3463 None 53 Human Functional pIC50 = 5.5 5.5 -5623 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
10071196 3124 None 53 Human Functional pIC50 = 5.5 5.5 -218 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
10071196.0 3124 None 53 Human Functional pIC50 = 5.5 5.5 -218 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
5142 3124 None 53 Human Functional pIC50 = 5.5 5.5 -218 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
8423 3124 None 53 Human Functional pIC50 = 5.5 5.5 -218 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
CHEMBL2111101 3124 None 53 Human Functional pIC50 = 5.5 5.5 -218 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
DB05316 3124 None 53 Human Functional pIC50 = 5.5 5.5 -218 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.6019/CHEMBL5442687
3929516 107426 None 4 Human Functional pIC50 = 5.5 5.5 1 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 343 4 0 2 4.7 CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2 10.6019/CHEMBL5442687
CHEMBL317757 107426 None 4 Human Functional pIC50 = 5.5 5.5 1 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 343 4 0 2 4.7 CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2 10.6019/CHEMBL5442687
CHEMBL543113 107426 None 4 Human Functional pIC50 = 5.5 5.5 1 2
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 343 4 0 2 4.7 CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2 10.6019/CHEMBL5442687
276 3513 None 37 Human Functional pIC50 = 5.4 5.4 -1905 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 451 5 2 6 4.1 COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl 10.6019/CHEMBL5442687
5312149 3513 None 37 Human Functional pIC50 = 5.4 5.4 -1905 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 451 5 2 6 4.1 COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl 10.6019/CHEMBL5442687
CHEMBL431298 3513 None 37 Human Functional pIC50 = 5.4 5.4 -1905 5
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 451 5 2 6 4.1 COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl 10.6019/CHEMBL5442687
10390 2119 None 40 Human Functional pIC50 = 5.4 5.4 4 3
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 10.6019/CHEMBL5442687
57382073 2119 None 40 Human Functional pIC50 = 5.4 5.4 4 3
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 10.6019/CHEMBL5442687
CHEMBL4760718 2119 None 40 Human Functional pIC50 = 5.4 5.4 4 3
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 10.6019/CHEMBL5442687
CHEMBL4803066 2119 None 40 Human Functional pIC50 = 5.4 5.4 4 3
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 10.6019/CHEMBL5442687
44634573 2748 None 1 Human Functional pIC50 = 5.2 5.2 -724 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
9168 2748 None 1 Human Functional pIC50 = 5.2 5.2 -724 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
CHEMBL1474387 2748 None 1 Human Functional pIC50 = 5.2 5.2 -724 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
CHEMBL1622930 2748 None 1 Human Functional pIC50 = 5.2 5.2 -724 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1GPCR PRESTO-Tango dose-response in antagonist mode with target: CX3CR1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
10390 2119 None 40 Human Functional pIC50 = 9.5 9.5 4 3
Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.
Guide to Pharmacology 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 27001765
57382073 2119 None 40 Human Functional pIC50 = 9.5 9.5 4 3
Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.
Guide to Pharmacology 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 27001765
CHEMBL4760718 2119 None 40 Human Functional pIC50 = 9.5 9.5 4 3
Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.
Guide to Pharmacology 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 27001765
CHEMBL4803066 2119 None 40 Human Functional pIC50 = 9.5 9.5 4 3
Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.Measuring the inhibition of FKN-stimulated ERK1/2 phosphorylation.
Guide to Pharmacology 419 5 0 4 5.2 Clc1ccc(cc1)C1CCN(CC1)CCCn1c(=O)c2cccn2c2c1cccc2 27001765
856 1270 None 0 Human Functional pIC50 = 8.9 8.9 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14607932




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

71293797 172400 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 501 8 2 4 4.6 Cc1cccc(Cl)c1CN1C[C@H](C)[C@](CC(=O)O)(C(=O)NC2CCN(CC3=CCCCC3)CC2)C1 nan
CHEMBL4475030 172400 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 501 8 2 4 4.6 Cc1cccc(Cl)c1CN1C[C@H](C)[C@](CC(=O)O)(C(=O)NC2CCN(CC3=CCCCC3)CC2)C1 nan
71293723 170156 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 539 9 2 4 5.4 C[C@H]1CN(Cc2c(Cl)cccc2C(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2CCCCC2)CC1 nan
CHEMBL4442967 170156 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 539 9 2 4 5.4 C[C@H]1CN(Cc2c(Cl)cccc2C(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2CCCCC2)CC1 nan
71293703 175051 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 549 10 2 4 5.0 CCCC(F)CN1CCC(NC(=O)[C@]2(CC(=O)O)CN(Cc3c(Cl)cccc3C(F)(F)F)C[C@@H]2C)CC1 nan
CHEMBL4565523 175051 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 549 10 2 4 5.0 CCCC(F)CN1CCC(NC(=O)[C@]2(CC(=O)O)CN(Cc3c(Cl)cccc3C(F)(F)F)C[C@@H]2C)CC1 nan
71293644 174481 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 527 12 2 4 5.4 CCCCCCN1CCC(NC(=O)[C@]2(CC(=O)O)CN(Cc3c(Cl)cccc3C(F)F)C[C@@H]2C)CC1 nan
CHEMBL4551880 174481 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 527 12 2 4 5.4 CCCCCCN1CCC(NC(=O)[C@]2(CC(=O)O)CN(Cc3c(Cl)cccc3C(F)F)C[C@@H]2C)CC1 nan
71293790 169653 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 523 9 2 4 4.9 C[C@H]1CN(Cc2c(Cl)cccc2C(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCC2)CC1 nan
CHEMBL4435586 169653 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 523 9 2 4 4.9 C[C@H]1CN(Cc2c(Cl)cccc2C(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCC2)CC1 nan
71293710 170194 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 507 8 2 4 4.6 C[C@H]1CN(Cc2c(Cl)cccc2Cl)C[C@@]1(CC(=O)O)C(=O)N[C@H]1CCN(CC2=CCCCC2)C1 nan
CHEMBL4443425 170194 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 507 8 2 4 4.6 C[C@H]1CN(Cc2c(Cl)cccc2Cl)C[C@@]1(CC(=O)O)C(=O)N[C@H]1CCN(CC2=CCCCC2)C1 nan
71293610 171105 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 559 8 2 4 5.3 C[C@H]1CN(Cc2c(Cl)cccc2Cl)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2CCC(F)(F)CC2)CC1 nan
CHEMBL4456446 171105 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 559 8 2 4 5.3 C[C@H]1CN(Cc2c(Cl)cccc2Cl)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2CCC(F)(F)CC2)CC1 nan
71293715 170470 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 487 8 2 4 4.3 Cc1cccc(Cl)c1CN1C[C@H](C)[C@](CC(=O)O)(C(=O)NC2CCN(CC3=CCCC3)CC2)C1 nan
CHEMBL4447653 170470 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 487 8 2 4 4.3 Cc1cccc(Cl)c1CN1C[C@H](C)[C@](CC(=O)O)(C(=O)NC2CCN(CC3=CCCC3)CC2)C1 nan
71293692 173124 None 21 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 555 8 2 4 5.4 C[C@H]1CN(Cc2c(Cl)cccc2C(F)(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1 nan
CHEMBL4518556 173124 None 21 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 555 8 2 4 5.4 C[C@H]1CN(Cc2c(Cl)cccc2C(F)(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1 nan
71293607 173977 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 541 8 2 4 5.0 C[C@H]1CN(Cc2c(Cl)cccc2C(F)(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCC2)CC1 nan
CHEMBL4539605 173977 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 541 8 2 4 5.0 C[C@H]1CN(Cc2c(Cl)cccc2C(F)(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCC2)CC1 nan
71293699 172327 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 521 8 2 4 5.0 C[C@H]1CN(Cc2c(Cl)cccc2Cl)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1 nan
CHEMBL4474066 172327 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 521 8 2 4 5.0 C[C@H]1CN(Cc2c(Cl)cccc2Cl)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1 nan
71293737 175566 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 537 9 2 4 5.3 C[C@H]1CN(Cc2c(Cl)cccc2C(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1 nan
CHEMBL4577003 175566 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assayAntagonist activity at CX3CR1 (unknown origin) expressed in mouse B300 cells assessed as inhibition of fractalkine-induced chemotaxis incubated for 30 mins and measured after 3.5 hrs by Cell Titer assay
ChEMBL 537 9 2 4 5.3 C[C@H]1CN(Cc2c(Cl)cccc2C(F)F)C[C@@]1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1 nan
132072454 179830 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at human CX3CR1 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CX3CR1 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179830 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at human CX3CR1 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CX3CR1 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
69440865 88403 None 0 Human Binding pKi = 8 8.0 -2 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 426 8 3 7 3.8 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349306 88403 None 0 Human Binding pKi = 8 8.0 -2 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 426 8 3 7 3.8 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)sc12 10.1021/jm3012273
59799570 88437 None 0 Human Binding pKi = 7 7.0 5 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 375 8 3 8 3.5 CCC[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349339 88437 None 0 Human Binding pKi = 7 7.0 5 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 375 8 3 8 3.5 CCC[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71625506 88413 None 0 Human Binding pKi = 7.0 7.0 58 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 481 8 3 8 5.1 CC(C)C[C@H](CO)Nc1nc(S[C@H](C)c2ccccc2Br)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349315 88413 None 0 Human Binding pKi = 7.0 7.0 58 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 481 8 3 8 5.1 CC(C)C[C@H](CO)Nc1nc(S[C@H](C)c2ccccc2Br)nc2nc(N)sc12 10.1021/jm3012273
71625504 88388 None 0 Human Binding pKi = 7.0 7.0 4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 417 10 3 8 4.2 CC(C)C[C@H](CO)Nc1nc(SCCCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349183 88388 None 0 Human Binding pKi = 7.0 7.0 4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 417 10 3 8 4.2 CC(C)C[C@H](CO)Nc1nc(SCCCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71624890 88389 None 0 Human Binding pKi = 7.0 7.0 -1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 422 8 3 8 2.2 CC(C)C[C@H](CO)Nc1nc(S(=O)(=O)Cc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349184 88389 None 0 Human Binding pKi = 7.0 7.0 -1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 422 8 3 8 2.2 CC(C)C[C@H](CO)Nc1nc(S(=O)(=O)Cc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
11857680 97683 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 347 6 3 8 2.8 C[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL271013 97683 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 347 6 3 8 2.8 C[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71625274 88424 None 0 Human Binding pKi = 6.9 6.9 33 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 3.7 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2C#N)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349326 88424 None 0 Human Binding pKi = 6.9 6.9 33 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 3.7 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2C#N)nc2nc(N)sc12 10.1021/jm3012273
71625145 88392 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 417 8 3 8 4.6 CC(C)C[C@@H](Nc1nc(SCc2ccccc2)nc2nc(N)sc12)C(C)(C)O 10.1021/jm3012273
CHEMBL2349187 88392 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 417 8 3 8 4.6 CC(C)C[C@@H](Nc1nc(SCc2ccccc2)nc2nc(N)sc12)C(C)(C)O 10.1021/jm3012273
71625390 88429 None 0 Human Binding pKi = 5.9 5.9 -4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 3.7 CC(C)C[C@H](CO)Nc1nc(SCc2ccc(C#N)cc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349331 88429 None 0 Human Binding pKi = 5.9 5.9 -4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 3.7 CC(C)C[C@H](CO)Nc1nc(SCc2ccc(C#N)cc2)nc2nc(N)sc12 10.1021/jm3012273
71625505 88412 None 0 Human Binding pKi = 7.9 7.9 204 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 481 8 3 8 5.1 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2Br)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349314 88412 None 0 Human Binding pKi = 7.9 7.9 204 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 481 8 3 8 5.1 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2Br)nc2nc(N)sc12 10.1021/jm3012273
66622526 88416 None 0 Human Binding pKi = 7.9 7.9 64 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 415 8 3 8 3.7 CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(C#N)c2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349318 88416 None 0 Human Binding pKi = 7.9 7.9 64 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 415 8 3 8 3.7 CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(C#N)c2)nc2[nH]c(=O)sc12 10.1021/jm3012273
71625503 88387 None 0 Human Binding pKi = 7.8 7.8 19 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 9 3 8 3.8 CC(C)C[C@H](CO)Nc1nc(SCCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349182 88387 None 0 Human Binding pKi = 7.8 7.8 19 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 9 3 8 3.8 CC(C)C[C@H](CO)Nc1nc(SCCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
11964663 88409 None 0 Human Binding pKi = 7.8 7.8 117 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 4.3 CC(C)C[C@H](CO)Nc1nc(S[C@H](C)c2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349311 88409 None 0 Human Binding pKi = 7.8 7.8 117 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 4.3 CC(C)C[C@H](CO)Nc1nc(S[C@H](C)c2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71625146 88418 None 0 Human Binding pKi = 6.7 6.7 1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 389 6 3 8 3.8 CC(C)(C)[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349320 88418 None 0 Human Binding pKi = 6.7 6.7 1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 389 6 3 8 3.8 CC(C)(C)[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71720196 88386 None 0 Human Binding pKi = 7.7 7.7 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 425 8 3 8 3.9 CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cnccc2Cl)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349181 88386 None 0 Human Binding pKi = 7.7 7.7 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 425 8 3 8 3.9 CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cnccc2Cl)nc2[nH]c(=O)sc12 10.1021/jm3012273
71625021 88401 None 0 Human Binding pKi = 6.7 6.7 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 402 8 3 8 3.3 CC(C)C[C@@H](Nc1nc(SCc2ccccc2)nc2nc(N)sc12)C(N)=O 10.1021/jm3012273
CHEMBL2349304 88401 None 0 Human Binding pKi = 6.7 6.7 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 402 8 3 8 3.3 CC(C)C[C@@H](Nc1nc(SCc2ccccc2)nc2nc(N)sc12)C(N)=O 10.1021/jm3012273
71625143 88435 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 409 7 3 8 4.1 Nc1nc2nc(SCc3ccccc3)nc(N[C@@H](CO)c3ccccc3)c2s1 10.1021/jm3012273
CHEMBL2349337 88435 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 409 7 3 8 4.1 Nc1nc2nc(SCc3ccccc3)nc(N[C@@H](CO)c3ccccc3)c2s1 10.1021/jm3012273
71625272 88422 None 0 Human Binding pKi = 7.6 7.6 9 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 407 8 3 8 3.9 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2F)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349324 88422 None 0 Human Binding pKi = 7.6 7.6 9 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 407 8 3 8 3.9 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2F)nc2nc(N)sc12 10.1021/jm3012273
11964579 88417 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 481 9 3 10 3.7 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(S(C)(=O)=O)c2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349319 88417 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 481 9 3 10 3.7 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(S(C)(=O)=O)c2)nc2nc(N)sc12 10.1021/jm3012273
69442228 88390 None 0 Human Binding pKi = 6.6 6.6 1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 406 8 3 7 2.5 CC(C)C[C@H](CO)Nc1nc([S+]([O-])Cc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349185 88390 None 0 Human Binding pKi = 6.6 6.6 1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 406 8 3 7 2.5 CC(C)C[C@H](CO)Nc1nc([S+]([O-])Cc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
12073809 155392 None 0 Human Binding pKi = 4.5 4.5 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 348 6 3 7 2.5 C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL402986 155392 None 0 Human Binding pKi = 4.5 4.5 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 348 6 3 7 2.5 C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
11965767 88408 None 36 Human Binding pKi = 8.4 8.4 33 3
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 4.3 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349310 88408 None 36 Human Binding pKi = 8.4 8.4 33 3
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 4.3 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
57692074 88419 None 0 Human Binding pKi = 7.5 7.5 2 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 7 3.5 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349321 88419 None 0 Human Binding pKi = 7.5 7.5 2 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 7 3.5 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
71625276 88426 None 0 Human Binding pKi = 7.5 7.5 6 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 467 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(Br)c2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349328 88426 None 0 Human Binding pKi = 7.5 7.5 6 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 467 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(Br)c2)nc2nc(N)sc12 10.1021/jm3012273
71625022 88402 None 0 Human Binding pKi = 6.5 6.5 18 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 3.9 CC(C)C[C@@H](Nc1nc(SCc2ccccc2)nc2nc(N)sc12)C(=O)O 10.1021/jm3012273
CHEMBL2349305 88402 None 0 Human Binding pKi = 6.5 6.5 18 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 3.9 CC(C)C[C@@H](Nc1nc(SCc2ccccc2)nc2nc(N)sc12)C(=O)O 10.1021/jm3012273
71625392 88404 None 0 Human Binding pKi = 6.4 6.4 -5 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 9 3.2 CC(C)C[C@H](CO)Nc1nc(SCc2ccccn2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349307 88404 None 0 Human Binding pKi = 6.4 6.4 -5 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 9 3.2 CC(C)C[C@H](CO)Nc1nc(SCc2ccccn2)nc2nc(N)sc12 10.1021/jm3012273
71625271 88420 None 0 Human Binding pKi = 8.4 8.4 436 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 467 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2Br)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349322 88420 None 0 Human Binding pKi = 8.4 8.4 436 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 467 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2Br)nc2nc(N)sc12 10.1021/jm3012273
11964664 88414 None 0 Human Binding pKi = 8.3 8.3 301 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 421 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2F)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349316 88414 None 0 Human Binding pKi = 8.3 8.3 301 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 421 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2F)nc2nc(N)sc12 10.1021/jm3012273
71625625 88415 None 0 Human Binding pKi = 7.4 7.4 309 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 4.0 CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(C#N)c2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349317 88415 None 0 Human Binding pKi = 7.4 7.4 309 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 4.0 CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(C#N)c2)nc2nc(N)sc12 10.1021/jm3012273
71625019 88399 None 0 Human Binding pKi = 7.4 7.4 97 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 451 8 2 9 4.6 COC(=O)[C@@H](CC(C)C)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349302 88399 None 0 Human Binding pKi = 7.4 7.4 97 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 451 8 2 9 4.6 COC(=O)[C@@H](CC(C)C)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12 10.1021/jm3012273
69441619 88391 None 0 Human Binding pKi = 7.4 7.4 13 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 374 8 3 7 2.8 CC(C)C[C@H](CO)Nc1nc(OCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349186 88391 None 0 Human Binding pKi = 7.4 7.4 13 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 374 8 3 7 2.8 CC(C)C[C@H](CO)Nc1nc(OCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
71625389 88428 None 0 Human Binding pKi = 7.3 7.3 33 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 467 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(SCc2ccc(Br)cc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349330 88428 None 0 Human Binding pKi = 7.3 7.3 33 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 467 8 3 8 4.5 CC(C)C[C@H](CO)Nc1nc(SCc2ccc(Br)cc2)nc2nc(N)sc12 10.1021/jm3012273
58230405 88433 None 0 Human Binding pKi = 7.3 7.3 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 389 8 3 8 3.8 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349335 88433 None 0 Human Binding pKi = 7.3 7.3 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 389 8 3 8 3.8 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71718998 88385 None 0 Human Binding pKi = 8.2 8.2 85 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 439 8 3 8 4.1 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2cc(Cl)ccn2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349180 88385 None 0 Human Binding pKi = 8.2 8.2 85 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 439 8 3 8 4.1 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2cc(Cl)ccn2)nc2[nH]c(=O)sc12 10.1021/jm3012273
58230407 88421 None 1 Human Binding pKi = 7.3 7.3 34 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 423 8 3 8 4.4 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349323 88421 None 1 Human Binding pKi = 7.3 7.3 34 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 423 8 3 8 4.4 CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12 10.1021/jm3012273
11858153 88432 None 0 Human Binding pKi = 6.3 6.3 -26 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 362 7 3 7 2.9 CC[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349334 88432 None 0 Human Binding pKi = 6.3 6.3 -26 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 362 7 3 7 2.9 CC[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
71716556 88384 None 0 Human Binding pKi = 8.2 8.2 181 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 438 8 3 9 4.4 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2cc(Cl)ccn2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349179 88384 None 0 Human Binding pKi = 8.2 8.2 181 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 438 8 3 9 4.4 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2cc(Cl)ccn2)nc2nc(N)sc12 10.1021/jm3012273
71625024 88434 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 389 8 3 8 3.8 CC(C)C[C@@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349336 88434 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 389 8 3 8 3.8 CC(C)C[C@@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71625144 88436 None 0 Human Binding pKi = 6.2 6.2 -4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 375 7 3 8 3.4 CC(C)[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349338 88436 None 0 Human Binding pKi = 6.2 6.2 -4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 375 7 3 8 3.4 CC(C)[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71625501 88405 None 0 Human Binding pKi = 6.2 6.2 7 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 9 3.2 CC(C)C[C@H](CO)Nc1nc(SCc2cccnc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349308 88405 None 0 Human Binding pKi = 6.2 6.2 7 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 9 3.2 CC(C)C[C@H](CO)Nc1nc(SCc2cccnc2)nc2nc(N)sc12 10.1021/jm3012273
11857488 88410 None 4 Human Binding pKi = 8.1 8.1 26 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 404 8 3 7 4.1 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349312 88410 None 4 Human Binding pKi = 8.1 8.1 26 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 404 8 3 7 4.1 CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
71625273 88423 None 0 Human Binding pKi = 7.2 7.2 21 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 4.1 Cc1ccccc1CSc1nc(N[C@@H](CO)CC(C)C)c2sc(N)nc2n1 10.1021/jm3012273
CHEMBL2349325 88423 None 0 Human Binding pKi = 7.2 7.2 21 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 403 8 3 8 4.1 Cc1ccccc1CSc1nc(N[C@@H](CO)CC(C)C)c2sc(N)nc2n1 10.1021/jm3012273
71625391 88431 None 0 Human Binding pKi = 7.2 7.2 1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 425 8 3 8 4.1 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349333 88431 None 0 Human Binding pKi = 7.2 7.2 1 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 425 8 3 8 4.1 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12 10.1021/jm3012273
9885291 98340 None 0 Human Binding pKi = 6.1 6.1 -4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 361 7 3 8 3.1 CC[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL274737 98340 None 0 Human Binding pKi = 6.1 6.1 -4 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 361 7 3 8 3.1 CC[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
11857486 88411 None 0 Human Binding pKi = 8.1 8.1 169 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 404 8 3 7 4.1 CC(C)C[C@H](CO)Nc1nc(S[C@H](C)c2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
CHEMBL2349313 88411 None 0 Human Binding pKi = 8.1 8.1 169 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 404 8 3 7 4.1 CC(C)C[C@H](CO)Nc1nc(S[C@H](C)c2ccccc2)nc2[nH]c(=O)sc12 10.1021/jm3012273
21035680 88430 None 0 Human Binding pKi = 8.1 8.1 69 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 485 8 3 8 4.7 CC(C)C[C@H](CO)Nc1nc(SCc2ccc(Br)cc2F)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349332 88430 None 0 Human Binding pKi = 8.1 8.1 69 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 485 8 3 8 4.7 CC(C)C[C@H](CO)Nc1nc(SCc2ccc(Br)cc2F)nc2nc(N)sc12 10.1021/jm3012273
71625020 88400 None 0 Human Binding pKi = 8.1 8.1 234 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 417 8 2 9 4.0 COC(=O)[C@@H](CC(C)C)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349303 88400 None 0 Human Binding pKi = 8.1 8.1 234 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 417 8 2 9 4.0 COC(=O)[C@@H](CC(C)C)Nc1nc(SCc2ccccc2)nc2nc(N)sc12 10.1021/jm3012273
71625502 88406 None 0 Human Binding pKi = 6.1 6.1 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 9 3.2 CC(C)C[C@H](CO)Nc1nc(SCc2ccncc2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349309 88406 None 0 Human Binding pKi = 6.1 6.1 10 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 390 8 3 9 3.2 CC(C)C[C@H](CO)Nc1nc(SCc2ccncc2)nc2nc(N)sc12 10.1021/jm3012273
71624891 88398 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 437 9 3 8 4.8 CC(C)C[C@H](CCO)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349301 88398 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 437 9 3 8 4.8 CC(C)C[C@H](CCO)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12 10.1021/jm3012273
58230406 88427 None 0 Human Binding pKi = 7.0 7.0 21 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 3.7 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(C#N)c2)nc2nc(N)sc12 10.1021/jm3012273
CHEMBL2349329 88427 None 0 Human Binding pKi = 7.0 7.0 21 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 414 8 3 9 3.7 CC(C)C[C@H](CO)Nc1nc(SCc2cccc(C#N)c2)nc2nc(N)sc12 10.1021/jm3012273
71625275 88425 None 0 Human Binding pKi = 7 7.0 5 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 419 9 3 9 3.8 COc1ccccc1CSc1nc(N[C@@H](CO)CC(C)C)c2sc(N)nc2n1 10.1021/jm3012273
CHEMBL2349327 88425 None 0 Human Binding pKi = 7 7.0 5 2
Displacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysisDisplacement of [125I]-CX3CL1 from human CX3CR1 transfected in HEK293 cells after 24 hrs by scintillation counting analysis
ChEMBL 419 9 3 9 3.8 COc1ccccc1CSc1nc(N[C@@H](CO)CC(C)C)c2sc(N)nc2n1 10.1021/jm3012273